history of cvd-mali
CVD-Mali was created in 2001, by an agreement between the Government of Mali through the Ministry of Health and the University of Maryland in the United States of America through its Center for Vaccine Development.
CVD-Mali’s core work since its inception has revolved around quantifying the burden of vaccine-preventable diseases, and testing the safety, immunogenicity and efficacy of new vaccines.
CVD-Mali also plays an important role in the training of young investigators in Mali and around the world. CVD-Mali shares all of its research results with the Ministry of Health to guide public health decisions.
In recent years, alongside its core vaccine-related work, it has partnered with many international organisations, to deliver public health research and interventions – most notably ABCD, Champs, and two ongoing Bill and Melinda Gates Foundation-funded azithromycin trials in the Sikasso and Kayes regions of Mali.